COMMUNITY-ACQUIRED PNEUMONIA COMPLICATED BY SEPSIS CAUSED BY KLEBSIELLA PNEUMONIAE: A CASE REPORT
Abstract
The actuality of the problem of sepsis is currently determined by several causes: a significant frequency of the disease, high lethality and, consequently, significant economic damage caused by this disease in economically developed countries. The clinical picture is systematized and outlined, questions of laboratory diagnostics, the principles of treatment are defined. Analyzed pathological changes that occur in sepsis on the part of various organs and systems . Shown the diagnostic algorithm, which is acceptable both in the presence and in the absence of laboratory verification of the disease. Starting antibacterial therapy is recommended as an empirical therapy, depending on the localization of the primary focus and systemic manifestations of infection. Thus, considering the clinical case of sepsis, one should emphasize that it is important to collect detailed medical history (especially if broncho-pulmonary system is involved), to consider where the patient works and his/her profession (especially for health-care workers, and other categories of people who work with organized groups of population). It is advisable to assume a nosocomial infection as a pathogen.
Downloads
References
2. Heming N, Lamothe L, Ambrosi X, Annane D. Emerging drugs for the treatment of sepsis. Expert Opin Emerg Drugs. 2016;21(1):27-37.
3. Kidd TJ, Mills G, Sá-Pessoa J, Dumigan A, Frank CG, Insua JL, et al. A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence. EMBO Mol Med. 2017 Apr;9(4):430-447.
4. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006 Jun;34(6):1589-96.
5. Sun A, Netzer G, Small DS, Hanish A, Fuchs BD, Gaieski DF. Association Between Index Hospitalization and Hospital Readmission in Sepsis Survivrs. Crit Care Med. 2016 Mar;44(3):478-87.